Data is currently being updated. Some features may be temporarily unstable.

Disease Profile

Bacterial

Botulism

肉毒杆菌中毒

Botulism is a rare but potentially fatal neuroparalytic illness caused by botulinum toxin produced by Clostridium botulinum, an anaerobic spore-forming bacterium. The disease manifests through descending flaccid paralysis that can progress to respiratory failure, though consciousness typically remains intact and fever is absent. Four toxin types (A, B, E, and rarely F) cause human disease, with foodborne transmission being the classic route, though infant botulism, wound botulism, and rare inhalation exposure represent distinct epidemiologic forms. The disease is not transmitted person-to-person, and prevention centers on proper food processing and avoidance of known risk factors such as honey for infants.

Definition

Botulism is a rare and potentially fatal intoxication caused by botulinum toxin, a neurotoxin produced by the anaerobic, Gram-positive, spore-forming bacterium Clostridium botulinum. The disease results from exposure to one of seven immunologically distinct toxin types (A through G), of which types A, B, E, and rarely F are known to cause human illness. The toxin ranks among the most potent known biological substances, acting through inhibition of acetylcholine release at neuromuscular junctions to produce flaccid paralysis. Clostridium botulinum spores are heat-resistant and ubiquitous in soil, river, and sea water environments, germinating and producing toxin only under anaerobic conditions with appropriate temperature and preservative parameters.

Clinical features

Botulism onset typically begins with cranial nerve involvement, manifesting as blurred vision, diplopia, dysphagia, dysarthria, and facial weakness, accompanied by marked fatigue, weakness, and vertigo. Gastrointestinal symptoms including vomiting, diarrhea, constipation, and abdominal swelling frequently accompany the prodrome. The paralysis characteristically descends symmetrically from cranial to neck and arm muscles, ultimately affecting respiratory muscles and lower body musculature, potentially causing respiratory failure. Notably, consciousness remains unaffected and fever is typically absent. Mortality has declined substantially from approximately 50% to 7% over the past five decades with modern intensive care, though severe cases may require prolonged mechanical ventilation and rehabilitation, with many survivors experiencing persistent fatigue and respiratory symptoms.

Epidemiology

Botulism is a relatively rare disease globally but carries high morbidity and mortality when it occurs. Infant botulism is the most common form in Western countries, affecting primarily infants under six months of age when spores colonize the immature gut and release toxin; honey consumption is a documented risk factor in approximately one-fifth of infant cases. Foodborne botulism outbreaks are associated with improperly processed, home-canned or home-bottled foods with low oxygen content, particularly when pH exceeds 4.6 or storage conditions permit bacterial growth. Wound botulism, though rare, occurs predominantly among persons who inject street drugs, particularly black tar heroin, when spores enter traumatic wounds and proliferate anaerobically. Inhalation botulism does not occur naturally and remains a theoretical concern only in accidental or intentional aerosol release scenarios.

Transmission

Botulism is not transmitted from person to person. Foodborne transmission occurs through ingestion of pre-formed toxin in contaminated foods where C. botulinum has grown and produced toxin prior to consumption, typically in improperly processed, low-acid, low-oxygen foods. Infant botulism results from ingestion of spores that germinate in the intestinal tract and release toxin internally, a process facilitated by the immature gut microbiome and bile acid profiles of young infants. Wound botulism occurs when spores enter traumatic or injection-site wounds and reproduce in anaerobic environments. Inhalation exposure to aerosolized toxin is extraordinarily rare and not a natural transmission route.

Risk groups

Infants under six months of age are the primary risk group for infant botulism due to immature intestinal defenses that permit C. botulinum colonization and toxin production. Persons who inject street drugs, particularly black tar heroin, face elevated risk of wound botulism from spore introduction into traumatic or injection-site wounds. Consumers of improperly home-canned or home-bottled foods, especially those with low acidity and stored at ambient temperatures, constitute the primary risk population for foodborne botulism. Adults and children over approximately six months are generally protected against intestinal botulism by established gut microbiome and bile acid defenses, though rare cases of adult intestinal toxemia have been documented.

Prevention

Prevention of foodborne botulism centers on proper food preparation and preservation techniques, including adequate heat processing during canning, maintaining appropriate acidity (pH below 4.6), and controlling storage temperatures. Botulinum toxin, though not the spores, is destroyed by heating to temperatures exceeding 85°C (185°F) for more than five minutes; spore destruction requires more rigorous sterilization such as autoclaving. Infants under one year of age should not be fed honey due to the risk of spore contamination. Wound botulism prevention requires prompt medical attention for contaminated wounds and avoidance of injection drug use. No vaccine is currently available for general population use.

Surveillance note

Botulism surveillance requires high clinical suspicion given its rarity and the urgency of timely intervention. Laboratory confirmation is achieved through detection of botulinum toxin or C. botulinum in clinical specimens, food, or environmental samples. The descending, symmetric flaccid paralysis with preserved consciousness and absent fever represents a distinctive clinical footprint that should prompt immediate notification of public health authorities, as botulism is a notifiable disease in most jurisdictions and cluster detection may indicate ongoing exposure sources. Foodborne outbreaks require traceback investigations to identify contaminated food items, while infant botulism cases warrant inquiry regarding honey exposure and environmental factors.

Coding Register
ICD-10
ICD-11
Key Statistics
Total cases
67
Peak month
2021-07
Coverage
2 reporting countries · 2000-01-01 → 2026-05-02

Figure 1 | Full historical trajectories across all reporting countries.

Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.

Dataset Archive

Supplementary Data | Multi-country disease dataset

Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.

Rows
1,027
Data Version
2026-05-09
Coverage
Included metadata
Source links, scope, cadence

Source Register

Official sources and update cadences used to construct the downloadable dataset.

AU
Australia NINDSSmonthlymicrosoft_bi

Australia

Australian national notifiable diseases surveillance dashboard.

Official source
JP
JP NIID Weeklyweeklyweb

Japan

Japan weekly infectious disease surveillance via NIID/JIHS.

Official source
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.